9
total announcements
540468.BO · 15 min delayed
KMS Medisurgi Ltd
KMS Medisurgi Ltd has submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming that the regulation is not applicable to the company as all shares are in demat form and no re-materialisation requests were received during the quarter ended 30th September, 2026.
KMS Medisurgi Ltd
KMS Medisurgi Ltd announces the cessation of Mr. Hardik Rajnikant Bhatt as an Independent Director upon completion of his second term. The Board appreciates his contributions and services during his tenure.
KMS Medisurgi Ltd
KMS Medisurgi Ltd announces the cessation of Mr. Kamlesh Rajani Chunilal as an Independent Director, effective September 30, 2026, upon completion of his second term.
KMS Medisurgi Ltd
KMS Medisurgi Ltd has disclosed the voting results of its 28th Annual General Meeting (AGM), where all resolutions were passed. The company declared a final dividend of 0.5% per equity share for the financial year ended March 31, 2026, and re-appointed Mr. Rohan Devang Kanakia as a Director liable to retire by rotation.
KMS Medisurgi Ltd
KMS Medisurgi Ltd held its 28th Annual General Meeting (AGM) on September 30, 2026, where 17 shareholders were present. The meeting approved the financial statements, declared a dividend, and re-appointed a director. The proceedings will be disseminated to the stock exchange and the company's website within 24 hours.
KMS Medisurgi Ltd
KMS Medisurgi Ltd has announced the closure of its trading window under the SEBI (Prohibition of Insider Trading) Regulations, 2015, effective from October 1, 2026, until 48 hours after the declaration of its half-yearly financial results.
KMS Medisurgi Ltd
KMS Medisurgi Ltd has submitted its Annual Report for FY 2025-26, announcing an AGM on September 30, 2026, to adopt financial statements, declare a final dividend of ₹ 0.05 per equity share, and re-appoint a director.
KMS Medisurgi Ltd
KMS Medisurgi Ltd has informed BSE that a meeting of the Board of Directors is scheduled on 05/09/2026 to consider and approve various items including the 28th Annual General Meeting, financial statements, and final dividend.
KMS Medisurgi Ltd
KMS Medisurgi Ltd has informed BSE that it is not required to disclose a report on corporate governance as per Regulation 27(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, due to its listing on the BSE SME Platform.